Legal battle over telehealth access to abortion medication mifepristone
The Trump administration asked a judge to dismiss a lawsuit from three GOP-led states seeking to restrict telehealth access to abortion medication mifepristone, arguing the states don't have the legal right to sue. The states want the FDA to limit access to mifepristone and require in-office visits for prescriptions. The case is being considered by a Texas judge, but Department of Justice attorneys say the states can file the lawsuit elsewhere as the claims are beyond the time limit to sue.
Key Points
- Trump administration seeks to dismiss lawsuit from GOP-led states seeking to limit telehealth access to mifepristone
- States argue FDA should restrict telehealth prescriptions for mifepristone and require in-office visits
- Department of Justice says states lack legal standing to sue and claims are beyond time limit to file lawsuit
Pros
- Department of Justice defending access to abortion medication
Cons
- States' efforts to restrict access to mifepristone